2016 Montana Initiative 182

Initiative 182 was a 2016 ballot initiative that amended Montana law to legalize marijuana for medical use in the state. The initiative passed via public referendum on November 8, 2016 with 58% of voters supporting and 42% opposing.[1]

Elections in Montana
Federal government Presidential elections 1892 1896 1900 1904 1908 1912 1916 1920 1924 1928 1932 1936 1940 1944 1948 1952 1956 1960 1964 1968 1972 1976 1980 1984 1988 1992 1996 2000 2004 2008 2012 2016 2020 2024 Presidential primaries Democratic 2000 2004 2008 2016 2020 Republican 2008 2012 2016 2020 2024 U.S. Senate elections 1890 1895 1895 sp 1899 1901 1901 sp 1905 1907 1911 1913 1916 1918 1922 1924 1928 1930 1934 1934 sp 1936 1940 1942 1946 1948 1952 1954 1958 1960 1964 1966 1970 1972 1976 1978 1982 1984 1988 1990 1994 1996 2000 2002 2006 2008 2012 2014 2018 2020 2024 2026 U.S. House of Representatives elections 1889 1890 1892 1894 1896 1898 1900 1902 1904 1906 1908 1910 1912 1914 1916 1918 1920 1922 1924 1926 1928 1930 1932 1934 1936 1938 1940 1942 1944 1945 2nd sp 1946 1948 1950 1952 1954 1956 1958 1960 1962 1964 1966 1968 1969 2nd sp 1970 1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016 2017 AL sp 2018 2020 2022 2024
State government General elections 2010 2016 2018 2020 2022 Gubernatorial elections 1889 1892 1896 1900 1904 1908 1912 1916 1920 1924 1928 1932 1936 1940 1944 1948 1952 1956 1960 1964 1968 1972 1976 1980 1984 1988 1992 1996 2000 2004 2008 2012 2016 2020 2024 Secretary of State elections 2020 Attorney General elections 2020 Senate elections 2016 2018 2020 2022 House of Representatives elections 2000 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020 2022
Ballot measures 1894 Capital referendum 2004 Initiative 96 2012 Referendum 121 2016 Initiative 182 2020 Initiative 190

The text of the ballot measure states:[2]

I-182 renames the Montana Marijuana Act to the Montana Medical Marijuana Act and amends the Act. I-182 allows a single treating physician to certify medical marijuana for a patient diagnosed with chronic pain and includes post-traumatic stress disorder (PTSD) as a “debilitating medical condition” for which a physician may certify medical marijuana. Licensing requirements, fees and prohibitions are detailed for medical marijuana dispensaries and testing laboratories. I-182 repeals the limit of three patients for each licensed provider, and allows providers to hire employees to cultivate, dispense, and transport medical marijuana. I-182 repeals the requirement that physicians who provide certifications for 25 or more patients annually be referred to the board of medical examiners. I-182 removes the authority of law enforcement to conduct unannounced inspections of medical marijuana facilities, and requires annual inspections by the State.